Search

EHA Congratulates EHA Kick-Off Grant 2022 Winners

The Hague, December 8, 2022 – EHA Congratulates seven talented researchers in Hematology on their receipt of an EHA Kick-Off Grant 2022 after a rigorous selection process.

Read more

Publications

Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial
P. Sonneveld, A. Chanan-Khan, K. Weisel, A. K. Nooka, T. Masszi, M. Beksac, I. Spicka, V. Hungria, M. Munder, M.

Read more

Pivotal Ruxolitinib Data Shows Promise for Patients with PV.

 

Polycythemia vera (PV) is a chronic, incurable blood cancer with limited treatment options. If uncontrolled, PV can cause serious cardiovascular complications, such as stroke and heart attack.

Read more

EHA-Balkan Hematology Day 2023

EHA is joining forces with the national societies from the Balkan countries and co-organizing with them the 4th edition of the EHA-Balkan Hematology Day.

Read more

Major research funding calls are out now

First, the Innovative Medicines Initiative published its final call under the EU Seventh Framework Programme. Interestingly for hematologists, the call includes a project called ‘Blood-based biomarker assays for personalized tumour therapy: value of circulating biomarkers’.

Read more

EHA-AHK joint membership

How you can save money by becoming a joint member of EHA and the Asociacioni i Hematologëve të Kosovës. We've joined forces with the Asociacioni i Hematologëve të Kosovës (AHK) to offer a special joint membership deal.

Read more

EHA & ERN-EuroBloodNet Spotlight on Congenital Bone Marrow Failure (BMF) Syndromes Webinars

Register now on the ERN-EuroBloodNet website 

EHA & ERN-EuroBloodNet Spotlight on Congenital Bone Marrow Failure (BMF) Syndromes is an accredited European online educational program designed for healthcare professionals. It's jointly organized by EHA and ERN-EuroBloodNet.

Read more

Meeting Program

All times are in GMT-3, local time in Brazil.

Read more